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High-density microarrays offer a powerful
approach to detecting changes in gene
expression. Such analysis allows one to
identify transcriptional changes in thou-
sands of genes simultaneously. The applica-
tion of microarrays as well as bioinformatics
toward toxicology has resulted in the
creation of a new science termed toxico-
genomics. The ﬁeld of toxicogenomics uses
gene expression changes to identify mecha-
nisms of toxicity and to predict potential
toxicity on the basis of similarities of expres-
sion profiles to known toxicants. Several
recent publications have described the use
of microarray analysis to identify discrete
gene changes associated with a toxic
response (Gerhold et al. 1999, Holden et al.
2000, Reilly et al. 2001). In addition, our
research, as well as the research of others,
has shown that compounds associated with
a particular mechanism of toxicity yield
similar gene expression profiles (Bulera
et al. 2001; Hamadeh et al. 2002a, 2002b;
Thomas et al. 2001; Waring et al. 2001a,
2001b). Furthermore, these gene expression
profiles can be used to build a predictive
database encapsulating biological responses
to toxic insult. To date, the field of toxi-
cogenomics has largely concentrated on
hepatotoxicity, since the liver is the primary
target of most toxic responses and liver
injury is the principle reason for new drugs
being withdrawn from the market.
The question of which genes to analyze
in order to build an expression database for
hepatotoxicity is of paramount importance.
There are commercially available microarrays
specifically designed for use in toxicology,
yet the gene sequences on these microarrays
are derived mainly from DNA libraries
from normal or disease tissues and not from
tissues that have been challenged with xeno-
biotics. Ideally, one would like to analyze all
genes that have the potential to be tran-
scriptionally regulated during a hepatotoxic
response. Although there have been some
genes identiﬁed that are linked with hepato-
toxicity, the identiﬁcation of all genes regu-
lated by the liver in response to toxic insult
has yet to be resolved. This issue becomes
more complex in the rat, which is the
model often used in traditional toxicology
because much of the rat genome remains
unsequenced to date. To address this issue,
we have constructed a microarray contain-
ing sequences from a rat library highly
enriched for genes regulated by toxic com-
pounds in the liver. We demonstrate the
utility of this microarray by testing it
against three hepatotoxins: 3-methylchol-
anthrene (3-MC), Aroclor 1254, and cyclo-
propane carboxylic acid (CPCA).
Materials and Methods
Construction of subtractive hybridization
library. All rat liver RNA samples used in
sequence screening experiments were pre-
pared at Abbott Laboratories from 3-day
toxicity studies. Rats were treated with
52 different compounds previously associ-
ated with hepatotoxicity (Table 1). Male
Sprague-Dawley rats (Charles River
Laboratories, Portage, MI, USA) approxi-
mately 6–12 weeks of age and weighing
225–275 g were treated with vehicle (corn
oil or saline) or with compound. There
were three rats per treatment group. The
dosing methods used were oral, interperi-
toneal, or intravenous, depending on the
preferred method of delivery for the com-
pound. Two dose levels were chosen for
each compound. Rats were dosed daily for
3 days and sacriﬁced on day 4. Blood sam-
ples drawn from the animals at necropsy
were used to measure serum concentrations
or activities of blood urea nitrogen, creati-
nine, alanine amino transferase, aspartate
aminotransferase, gamma glutamyltrans-
ferase, alkaline phosphatase (Abbott
Laboratories Diagnostic Division), choles-
terol, triglycerides, bilirubin, glucose, total
protein, albumin, and globulins using an
Abbott Aeroset clinical chemistry analyzer
(Abbott Laboratories Diagnostic Division,
Abbott Park, IL, USA). The terminal body
weights and liver weights were recorded.
The left lateral lobe of the liver was
processed for histopathologic evaluation.
Approximately 100 mg from each liver was
placed into TRIzolâ reagent (Invitrogen
Life Technologies, Carlsbad, CA, USA) and
immediately homogenized using a Turrax
tissue grinder (Diagger, Vernon Hills, IL,
USA). The remaining portion of the liver
was retained frozen for future study.
Subtractive hybridization was per-
formed using the method of suppressive
subtractive hybridization (Diatchenko et al.
1996). A pool of liver RNA containing 10
mg from all rats treated with hepatotoxin
was made and subtracted against a pool of
liver RNA containing 150 mg from three
naïve rats. Subtraction was performed in
the reverse direction as well. Subtraction
efﬁciency was measured by quantitating the
levels of D-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) before and after
subtraction.
The two libraries were cloned into the
vector pCR2.1 (Invitrogen). The libraries
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Toxicogenomics | Articlewere sequenced by Incyte Genomics (Palo
Alto, CA, USA). A total of 16,128 reads
were sequenced, corresponding to 8,064
attempted reads for each library. Each
library was sequenced with M13 reverse
ET-terminator in one direction with a
sequencing efﬁciency of 92%. The average
length read was 350 bp.
Sequence similarity searching. Individual
sequence reads from the subtractive
hybridization libraries were compared to
the National Center for Biotechnology
Information nr and nt collections (Altschul
et al. 1994) using BLAST 2 (Altschul et al.
1997). Hits with E < 1e-8 were considered
signiﬁcant. Contiguous sequences (contigs)
were compared to a comprehensive collec-
tion of 364,170 nucleotide sequences for
Rattus norvegicus taken from GenBank
(http://www.ncbi.nlm.nih.gov), dbEST
(database of expressed sequence tags), and
RefSeq, also using BLAST 2. The threshold
for considering an alignment significant
required that it be at least 100 bp in length,
have at least 95% identity, and cover at
least 20% of the length of the shorter of
query and subject sequences.
Oligonucleotide probe design. A non-
redundant set of rat gene transcripts was
determined by clustering and assembly of
cDNA sequences from the subtractive
hybridization libraries and publicly available
sequences. Sequences were assigned into clus-
ters and assembled into contigs using a deriv-
ative of the Smith-Waterman algorithm
(Smith and Waterman 1981). From this,
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Table 1. Hepatotoxins and dose levels used in the subtractive hybridization study.
Low dose High dose Method
Compound (mg/kg/day) (mg/kg/day) Vehicle of delivery Reference for dose Type of lesion
3-Methylcholanthrene 10 100 Corn oil ip Kleeberg et al. 1975 Hypertrophy
Acetominophen 70 700 Saline Oral Smith et al. 1998 Necrosis
Actinomycin D 0.04 0.4 Saline iv Bader et al. 1974 Necrosis
Adriamycin 1 10 Saline iv Necrosis
Aﬂatoxin B1 0.05 0.5 Saline Oral Root et al. 1997 Necrosis
Allopurinol 10 100 Saline Oral Phospholipidosis
Allyl alcohol 10 40 Corn oil ip Ganey and Schultze 1995 Necrosis
Amiodarone 10 100 Saline ip Reasor et al. 1996 Phospholipidosis
ANIT 10 40 Saline Oral Chisholm and Dolphin 1996 Cholestasis
Aroclor 1254 100 400 Corn oil ip Wolfgang et al. 1990 Hypertrophy
Arsenic 2 20 Saline ip Mahaffey et al. 1981 Cirrhosis
Aspirin 15 150 Saline Oral Steatosis
Bezaﬁbrate 20 200 Saline Oral Beier et al. 1988 Cholestasis
Carbamazepine 50 250 Saline ip Regnaud et al. 1988 Necrosis
Carbon tetrachloride 100 1,000 Corn oil ip Wolfgang et al. 1990 Necrosis
Chlorpromazine 25 100 Saline Oral Cholestasis
Cycloheximide 0.1 1.0 Saline iv Steatosis
Cyclophosphamide 10 100 Saline ip Brown et al. 1985 Necrosis
Dexamethasone 1 10 Saline iv Varying
Diclofenac 10 40 Saline Oral Cirrhosis
Diethylnitrosamine 10 100 Saline ip Williams et al. 1996 Necrosis
Diethylstilbestrol 2.5 25 Corn oil ip Tumor formation
Dimethyl formamide 100 1,000 Saline ip Mathew et al. 1980 Necrosis
Dinitrophenol 5 25 Saline Oral Steatosis
Diquat 17.2 68.8a Saline ip Wolfgang et al. 1991 Necrosis
Erythromycin 80 800 Saline Oral Kaltiala et al. 1967 Cholestasis
Estradiol glucuronide 1 10 Saline iv Cholestasis
Ethanol ND 3,000 Saline Oral Speisky et al. 1985 Steatosis
Etoposide 5 50 Saline ip Linden 1989 Necrosis
Galactosamine 50 500 Saline iv Steatosis
Ibuprofen 20 200 Saline Oral Adams et al. 1969 Cholestasis
Indomethacin 2 20 Saline ip Fracasso et al. 1987 Cholestasis
Iodoacetic acid 5 50 Saline iv Varying
Iron dextran 50 500 Saline ip Younes et al. 1989 Necrosis
Ketoconazole 30 120 Saline Oral Heel et al. 1982 Hepititis
L-Ethionine 5 50 Saline ip Steatosis
Methapyrilene 5 50 Saline ip Graichen et al. 1985 Steatosis
Methotrexate 50 250 Saline ip Custer et al. 1977 Steatosis
Microcystin 0.005 0.05 Saline iv Necrosis
Monocrotaline 5 50 Saline ip Perazzo et al. 1999 Necrosis
Nicotinic acid 200 2,000 Saline Oral Cholestasis
Oligomycin 0.1 1.0 Saline iv Kramar et al. 1984 Steatosis
Perhexilene 32 320 Saline Oral Phospholipidosis
Phenytoin 45 450 Saline Oral Garzon De la Mora et al. 1990 Cholestasis
Quinidine 7.5 75 Saline iv Varying
Retinol 50 500 Saline Oral Lettinga et al. 1996 Steatosis
Tamoxifen 5 50 Saline Oral Wogan 1997 Cholestasis
Tetracycline 50 500 Saline Oral Steatosis
Tumor necrosis factor-α 0.001 0.010 Saline iv Hepititis
Trovaﬂoxacin 150 400 Saline Oral Necrosis
Valproic acid 50 500 Saline Oral Kesterson et al. 1984 Steatosis
Verapamil 40 200 Saline Oral Landon et al. 1986 Cholestasis
Abbreviations: ip, intraperitoneal; iv, intravenous; ND, not done. aAll animals in this treatment group died before day 3 and were not used. Where no reference is provided, dose levels were
selected from unpublished results.60-mer oligonucleotides were selected for the
microarray. The process of probe selection is
described in “Results.”
Expression profiling experiments. Rats
were treated with Aroclor 1254 (Monsanto,
St. Louis, MO, USA), 3-MC (Sigma
Chemicals, St. Louis, MO, USA), or CPCA
(Sigma) at levels previously shown to be
hepatotoxic but not lethal. Male Sprague-
Dawley rats approximately 6–12 weeks of
age and weighing 225–275 g were injected
intraperitoneally with vehicle (corn oil or
saline) or with Aroclor 1254 (400 mg/kg/
day) (Wolfgang et al. 1990), 3-MC (100
mg/kg/day) (Kleeberg et al. 1975), or
CPCA (500 mg/kg/day) (Ulrich et al.
1998) for 3 days, and rats were sacriﬁced on
day 4. Preparation of RNA was as described
above. Preparation of labeled cDNA from
the RNA, hybridization and scanning of the
microarray were performed at Rosetta
Inpharmatics (Kirkland, WA, USA) as
described previously (Marton et al. 1998).
For microarray analysis, tRNA from indi-
vidual treated animals was hybridized
against RNA from a pool of three vehicle-
treated animals. Data analysis was per-
formed using the Rosetta Resolver system
(Rosetta). The fold change and p-value cal-
culations have been previously described
(Hughes et al. 2000).
Results
Subtractive hybridization. All rat liver RNA
samples used in sequence screening experi-
ments were prepared at Abbott Laboratories
from 3-day toxicity studies. Rats were
treated with 52 different compounds that
have been previously associated with hepa-
totoxicity (Table 1). The selected com-
pounds induced a hepatotoxic response by a
variety of observed mechanisms, including
necrosis, steatosis, DNA damage, cirrhosis,
hypertrophy, phospholipidosis, and hepatic
carcinoma. A 3-day time point was chosen
to accommodate induction of liver genes
without complication of a significant sec-
ondary inflammatory response (cellular
inﬁltration) or ﬁbrosis likely to be encoun-
tered over longer periods. Also, an earlier
time point would likely have included
immediate early response genes.
Using suppressive subtractive hybridi-
zation (Diatchenko et al. 1996), we per-
formed a subtractive hybridization in both
directions using pooled RNA from all
hepatotoxin-treated rats against liver RNA
from naïve rats to enrich for genes regu-
lated during a hepatotoxic response. By
performing the subtractive hybridization in
both directions, genes that are both upreg-
ulated (higher in treated animals) and
downregulated (higher in naïve animals)
should be enriched. We used polymerase
chain reaction to analyze the efﬁciency of the
subtractive hybridization by measuring the
levels of GAPDH before and after subtrac-
tion. The results indicated that we obtained
between 10- and 15-fold subtraction effi-
ciency (unpublished data). Sequences were
obtained for 14,523 clones. Of these
sequences, 16% had no signiﬁcant similarity
to known public domain sequences from
any organism.
Oligonucleotide probe design. The first
step in microarray design was to select a
nonredundant set of rat gene transcripts by
clustering and assembly of cDNA sequences.
The input to clustering included 14,523
sequences from subtractive hybridization of
hepatotoxin-treated rats (described above)
and 92,319 public domain sequences.
Sequences were assigned into clusters and
assembled into contigs on the basis of
sequence similarities identiﬁed by a deriva-
tive of the Smith–Waterman algorithm
(Smith and Waterman 1981). This process
resulted in 43,954 clusters and 54,437 con-
tigs. For purposes of probe design, each clus-
ter was represented by its longest contig
sequence. Some genes of interest, notably
those encoding cytochrome P450 enzymes
(CYP genes), are difficult to cluster accu-
rately with automated methods because of
high levels of homology between distinct
family members. CYP sequences were
curated and clustered manually on the basis
of their annotation and sequence similarity.
Sequences were prioritized and ordered in
terms of their biological interest and quality
of annotation.
The 14,523 sequences from the subtrac-
tive hybridization libraries fell into 2,728
clusters, suggesting that they represent
approximately this number of genes.
Comparison of representative contig
sequences for these clusters against public
domain rat sequences showed no signiﬁcant
hits for 555 sequences (20%). This suggests
that around 20% of the genes represented in
the subtractive hybridization libraries have
not previously been described in the rat.
A single 60-mer oligonucleotide probe
was selected to represent each input
sequence. All possible probes within 900 bp
of the 3´ end of each sequence were consid-
ered candidates for selection. Probes closer
to the 3´ end were favored because the
polyA-dependent sample preparation results
in higher hybridization intensities closer to
the 3´ end of each transcript. Up to 12
probes (6 from each strand) were selected
for each of 1,342 sequences for purposes of
sequence orientation and empirical selec-
tion of the best probes. Of these sequences,
1,227 were of biological interest (e.g.,
because they arose from the subtractive
hybridization libraries) but were of unknown
orientation. A further 115 sequences of
known orientation were included to pro-
vide training data for the orientation algo-
rithms. For the selection of multiple probes,
all probes within 900 bp of both ends were
considered. Candidate probes were passed
through a series of ﬁlters. First, probes con-
taining repeat elements, vector contamina-
tion, or low-complexity sequences were
eliminated. The best probes were then
selected on the basis of a combination of
sequence complexity, base composition,
predicted thermodynamic properties, pre-
dicted cross-hybridization, and position
within the transcript (Hughes et al. 2001).
In total, 49,554 probes were selected and
printed on microarrays. These microarrays
were used in screening experiments to
determine which probes should be included
on the ﬁnal 25,000-probe microarray.
Empirical probe evaluation. Empirical
selection of probes on the basis of hybridiza-
tion data is useful for refining microarray
design in a number of ways. It enables the
identiﬁcation of genes of interest for a spe-
ciﬁc area of biological study, and it can lead
to improved annotation of those genes
(e.g., by revealing their orientation). It can
also provide enhanced selection of optimal
probes from a short list designed by com-
putational methods, for example, by identi-
fying probes subject to cross-hybridization.
These advantages are particularly relevant
when, as in this case, a microarray needs to
be focused on a particular area of biology
and when many input sequences are
incomplete and poorly annotated.
The microarrays designed as described
above were hybridized with samples rele-
vant to hepatotoxicity. A total of 52 drugs
and environmental toxins with cited liver
toxicities were assembled and used in dedi-
cated rat studies (Table 1). In these studies,
RNA samples derived from compound
treatments were pooled into nine groups,
each comprising three to seven compound-
treated rats. In total, 22 competitive
hybridization experiments with ﬂuor rever-
sal were performed: naïve liver versus each
sample pool for compound-treated liver
(including differing hybridization times)
and naïve liver versus isolated hepatocytes.
To aid subsequent analysis of kinetic differ-
ences in hybridization intensity, one sample
pool was also hybridized at two time points:
4 hr and 48 hr.
An important aspect of empirical probe
selection was to orient sequences for which
direction could not be determined reliably
by computation alone. The direction of the
sequences was thus inferred experimentally
by consideration of a combination of three
factors: hybridization intensity, differential
expression, and kinetics of hybridization
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These criteria were used because probes
detecting the transcribed strand should
a) give brighter signal intensity, b) be more
likely to show differential regulation
between the labeled samples, and c) show a
brighter hybridization signal at 48 hr com-
pared with 4 hr (Dai et al. 2002). A total of
1,227 unoriented sequences were screened
in this way by testing 12 oligonucleotide
probes, 6 in the forward direction and 6 in
the reverse (relative to the input sequence).
A further 115 training set gene sequences
with known orientation were also tested to
assess accuracy and train parameters.
Regarding hybridization kinetics for
determining the orientation of the
sequences, the significance of specific
hybridization for each probe was calculated
by comparing the intensity differences from
two time points (4 hr and 48 hr) to their
errors. For each sequence, six probes from
each direction were grouped together, and
the direction was predicted based on signiﬁ-
cance of forward versus reverse direction
hybridization (Figure 1). Using parameters
optimized for the training set, orientation
was predicted correctly for 74 of 115 (64%)
of training sequences, with 2 incorrect
(2.7% of predictions). The orientations of
67% of the unoriented sequences were
predicted using the same parameters.
Motivation for using differential regula-
tion to determine sequence orientation is
dictated by two considerations. First,
differential regulation is evidence of
sequence-speciﬁc hybridization since cross-
hybridization of DNA sequences to
oligonucleotide probes in most cases tends
to suppress differential regulation. Second,
signiﬁcant regulation leads to the selection
of oligonucleotide probes with intensity
above background levels. In this study, six
probes in each direction were averaged
together to get an estimation of the signiﬁ-
cance of regulation over 10 experiments.
The correct orientation was determined by
the strand that gave lower p-values for dif-
ferential regulation. Using parameters opti-
mized for the training set, orientation was
predicted correctly for 53 of 115 (46%) of
training sequences, with 4 incorrect (7.5%
of predictions). The orientations of 44% of
the unoriented sequences were predicted
using the same parameters.
Regarding intensity, it is clear that
probes in the correct orientation should
exhibit higher intensity for those sequences
expressed. In this study the average intensity
of forward strand probes for each sequence
was compared with that of the reverse strand
probes. The parameters for predicting the
correct direction were determined again by
optimizing for the training set sequences.
The resulting parameters predicted orienta-
tion correctly for 62 of 115 (53%) training
sequences, with 1 incorrect (1.6% of predic-
tions). They yielded orientations for 76% of
the unoriented sequences.
The error rates for all three types of
evidence were reduced by applying filters
on the basis of the observed trend in inten-
sity along the length of a sequence. The
polyT-primed RNA ampliﬁcation protocol
used in these experiments generally results
in higher intensities closer to the 3´ end of
a transcript. A correctly oriented sequence
should show a trend of increasing intensity
toward the 3´ end. A small subset of
sequences for which predictions were ini-
tially made did not ﬁt the expected pattern,
and their predictions were discarded. The
majority of these predictions were from the
intensity-based analysis alone.
A final step in empirical orientation of
sequences combined the predictions from
the above analyses. Kinetics predictions,
when available, took priority. Orientation
for the remaining sequences was predicted
by intensity or regulation, except that con-
tradictory predictions from these two
sources were discarded. With these criteria,
90 of 115 (78%) training sequences were
correctly predicted, with just 3 sequences
incorrect (3.3% of predictions). This trans-
lated into confident prediction for 78.5%
of unoriented sequences.
The use of a large-format screening
array made it possible to use 12 probes per
sequence of unknown orientation. Using
fewer probes would have yielded many of
the same orientations, but any reduction
would affect sensitivity. Simulations suggest
that reducing the number of probes per
sequence to 4 would have resulted in
50–90% of the sensitivity achieved with 12.
Selection of oligonucleotides for 25K
array. The second data analysis step was to
select approximately 25,000 oligonu-
cleotides of those screened to fit the final
25K rat liver microarray. All genes on the
25K microarray were represented by a sin-
gle probe. Single oligonucleotide probes on
inkjet arrays have been shown to reliably
report expression ratios in yeast and
mammalian cells (Hughes et al. 2001).
Probes for genes of special interest were
set aside for inclusion without any further
preselection or analysis. In particular, 60
sequences representing cytochrome P450
genes and 2,475 sequences derived from
subtracted hybridization libraries were auto-
matically included in the selection for the
25K microarray. An additional 1,142
sequences were selected on the basis that
they have known human orthologs
(Makalowski et al. 1998). These are particu-
larly useful in comparing and translating
gene expression patterns between organisms.
The remaining probes were prioritized in
terms of their differential regulation com-
pared with vehicle, by hybridization kinetics
(as an indication of speciﬁc hybridization),
and last, by their brightness ranking. These
criteria produced mainly overlapping sets of
probes. Application of a signiﬁcance thresh-
old in differential regulation (p < 0.2 in any
experiments) produced 17,508 probes for
potential inclusion on the final array.
Kinetic comparisons, which help separate
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Figure 1. (A) Image from 50K microarray. (B) Zoom in from A showing probe sets to determine orientation.
Red rectangles show examples of probe sets that allowed for correct determination of orientation. Each
rectangle contains six probes derived from the forward strand of a sequence followed by 6 probes derived
from the reverse complement strand of the sequence.specific and nonspecific hybridization,
resulted in 11,746 candidate probes.
Combining these two criteria and eliminat-
ing probes already selected for inclusion
enabled us to select 14,216 probes. Figure 2
summarizes the distribution of intensities for
all candidate probes with known orientation
and shows the average intensity distributions
for the applied criteria.
Final specifications for microarray.
Experimental screening of the approximate
50K probes provided valuable data to help
prioritize sequences for representation on a
25K probe microarray. The majority of
oligonucleotide probes (~14,000) selected
for the microarray were derived from combi-
nation of significant differential regulation
(p < 0.2 in any experiment) and favorable
hybridization kinetics (lower probabilities of
cross-hybridization) and biological interest.
A smaller proportion of probes (~6,000)
exhibiting lower (but significant) signal
intensity in screening experiments were also
included. The final breakdown for probe
selection is shown in Table 2.
Transcriptional regulation by hepatotox-
ins. To determine the utility of the microar-
ray toxicology, we examined gene changes
in the liver induced by two aromatic hydro-
carbons, Aroclor 1254 and 3-MC, and a
short-chain fatty acid, CPCA. All these
agents are well-described hepatotoxins, and
previous research has identiﬁed some genes
that are regulated by Aroclor 1254 and
3-MC (Borlak and Thum 2001; Jauregui et
al. 1991). We wanted to determine if the
subtractive hybridization enriched for genes
that are regulated during a hepatotoxic
response. Both Aroclor 1254 and 3-MC
were used in the subtractive hybridization
experiment, whereas CPCA was not. Rats
were treated with Aroclor 1254 at 400
mg/kg, 3-MC at 100 mg/kg, or CPCA at
500 mg/kg for 3 days (Table 1). Signiﬁcant
gene regulation was deﬁned as fold change
>1.5-fold over control with p ≤ 0.01.
Figure 3 shows a K-means clustering of
genes regulated by treatment with CPCA,
Aroclor 1254, 3-MC, or vehicle. When
expression proﬁles from individual animals
treated with vehicle control were compared
with a pool, the results show that relatively
few genes were significantly regulated
(Figure 3). In contrast, treatment with the
three hepatotoxins resulted in numerous
gene changes that were highly reproducible
across the three replicate animals for each
different treatment. Rats treated with
Aroclor 1254 and 3-MC yield similar pat-
terns of gene expression; the two com-
pounds signiﬁcantly regulated 786 genes in
common. Many of these genes have previ-
ously been shown to be regulated by
aromatic hydrocarbons, including cyto-
chromes P450 1A1, and 1B1, malic enzyme,
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Table 2. Breakdown of probe selection for 25K
chip.
Subtractive hybridization
Unoriented 927
Oriented 1,548
CYP gene sequences 60
RefSeq sequencesa 55
Sequences with human orthologs 1,144
Sequences selected by regulation
and/or kinetics 14,216
Sequences selected by intensity 6,449
Total 24,399
aUsed in training set for sequence orientation.
Regulation
Kinetics
Regulation + kinetics
All genes
1,000
800
600
400
200
0
–2 –1 0 1 2
Mean log (intensity)
Figure 2. Intensity distributions for probes selected for inclusion on the 25K array. Distribution of intensities
for all probes on the 50K array is plotted as blue bars. The cyan line describes probes selected through dif-
ferential regulation, the green line describes probes selected through kinetics, and the red line describes
probes selected by both methods.
Figure 3. K-means cluster showing the genes regulated by CPCA, 3-MC, Aroclor 1254, or vehicle control.
The results show the similarity in gene expression proﬁles between 3-MC and Aroclor 1254. The regulated
genes have been assigned to eight treatment groups.
–0.4 0 0.4
Log/(ratio)
CPCA #2
CPCA #1
CPCA #3
3-MC #2
3-MC #3
Aroclor #1
3-MC #1
Aroclor #2
Aroclor #3
Vehicle #1
Vehicle #2
Vehicle #3
12 3 4 5 6 7 8glutathione-S-transferase, and UDP-glu-
curonosyltransferase 1 (Figure 3, group 1)
(Borlak and Thum 2001; Jauregui et al.
1991; Lubet et al. 1991; Mehlman et al.
1975; Saarikoski et al. 1998). Other genes
regulated by 3-MC and Aroclor 1254 were
Erp29, liver tricarboxylate carrier, and
cholesterol hydroxylase 7α (Table 3).
CPCA is an inhibitor of β-oxidation
and has been shown to result in micro-
vesicular steatosis (Ulrich et al. 1998).
Therefore, it would be expected to result in
regulation of mitochondrial and peroxiso-
mal genes involved in β-oxidation. Table 3
shows that genes involved in mitochondrial
or peroxisomal β-oxidation such as
acyl–coenzyme A (acyl–CoA) dehydroge-
nase and enoyl–CoA hydratase were inhib-
ited by treatment with CPCA. Treatment
with CPCA also resulted in regulation of a
number of genes in the cholesterol and fatty
acid pathways, including an upregulation of
adipocyte lipid binding protein, squalene
epoxidase, 7-dehydrocholesterol reductase,
and downregulation of cholesterol hydroxy-
lase 7α, lecithin-cholesterol acyltransferase,
fatty acid desaturase, fatty acid amide
hydrolase, and fatty acid binding proteins 1
and 7 (Table 3).
Table 4 summarizes the gene regulation
for the three compounds. The results show
that the sequences from the subtractive
hybridization contributed significantly to
the expression profiles for the three com-
pounds. While these sequences represented
approximately 9% of the sequences on the
chip, they represented approximately 17%
of the signature profile for all three com-
pounds. This is true for all three com-
pounds despite the fact that CPCA was not
included in the set of compounds used in
the subtractive hybridization. This suggests
that the generation of the subtractive
hybridization library enriched for many
genes involved in responses to a wide range
of hepatotoxic compounds, not only those
treatments that were used. In addition,
roughly 5% of the regulated sequences were
identified in the subtractive hybridization
and have not been previously described.
Discussion
We have constructed a new rat toxicology
microarray using a strategy to specifically
represent genes that are regulated during a
hepatotoxic response. The strategy we
employed in constructing this array
provided several advantages over other
commercially available toxicology arrays.
First, we attempted to represent every gene
that can be regulated during a hepatotoxic
response. Toward this end, we dosed rats
with 52 known hepatotoxins using a com-
bination of drugs and chemicals that have
been associated with different mechanisms
of hepatotoxicity including DNA damage,
oxidative stress, peroxisomal proliferation,
necrosis, cirrhosis, steatosis, and protein
synthesis inhibitors. We sequenced approx-
imately 16,000 clones, which collapsed
down to roughly 2,700 contigs. Although
oligonucleotides representing the subtrac-
tive hybridization clones made up only 9%
of the ﬁnal 25K array, these sequences rep-
resented approximately 17% of the signa-
ture proﬁle for three different hepatotoxins.
In addition, many of the sequences from
the subtractive hybridization had not been
described previously. Some of these
sequences were regulated by the hepatotox-
ins tested and may be critical genes
involved in the mechanism of toxicity.
Further evidence of this is provided by
experiments performed with two com-
pounds considered to be nonhepatotoxic,
spectinomycin and penicillin. Microarray
results showed that these sequences were
regulated by the nonhepatotoxins to a
much lesser extent than by the three
hepatotoxic compounds, suggesting that
these sequences are relatively specific for a
hepatotoxic reaction (unpublished data).
The strategy we employed for the sub-
tractive hybridization does have inherent
limitations. Because the RNA from all the
treatment groups was pooled, it is possible a
gene that may have been up- or down-
regulated by only one hepatotoxin may not
be represented in the sequenced library. In
addition, if a gene was upregulated by half
the hepatotoxins and downregulated by the
other half, this gene also would likely be
missed. An alternative strategy would have
been to perform subtractive hybridization
on pooled RNA from compounds with sim-
ilar mechanisms of toxicity rather than pool-
ing all of the hepatotoxins. However, we
believe that the strategy we employed identi-
fied sufficient sequences to allow for the
classification of compounds into different
mechanistic classes.
Our strategy for chip construction is
similar to that employed by Thomas et al.
(2001). In this study, the authors con-
structed an environmental database for
gene expression (EDGE) composed of
libraries from mice treated with various
toxins, including dioxin and phenobarbi-
tol. These libraries were than used to con-
struct microarrays, which were used to
identify gene changes in mice treated with
compounds representing peroxisome
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Table 3. Some of the genes regulated by Aroclor 1254, 3-MC, or CPCA.
Cluster
Accession numbera Gene Aroclor 1254 3-MC CPCA (Fig. 3)
E00717 CYP1A1 30.06 36.65 NC 1
NM_012940 CYP1B1 63.13 100 NC 1
NM_012600 Malic enzyme 5.16 3.45 1.61 1
NM_017014 Glutathione-S-transferase 5.91 5.72 2.06 3
D83796 UDP-Glucuronosyltransferase 1 2.88 2.95 NC 3
U36482 Erp29 1.6 1.67 NC 3
AA964229 Tricarboxylate carrier –2.14 –2.68 NC 6
J05030 Acyl–CoA dehydrogenase NC NC –1.94 NS
D16478 Enoyl–CoA hydratase NC NC –1.35 NS
K03249 Peroxisomal bifunctional enzyme –1.84 –1.97 –5.41 7
J02749 Acetyl–CoA acyltransferase,
3-Oxo-acyl–CoA thiolase A, peroxisomal 4.23 2.93 –1.82 1
AI105060 Adipocyte lipid binding protein NC NC 4.66 2
D37920 Squalene epoxidase NC NC 10.21 2
AB016800 7-Dehydrocholesterol reductase NC NC 1.83 NS
J05509 Cholesterol hydroxylase 7α –7.81 –1.87 –5.52 7
NM_017024 Lecithin–cholesterol acyltransferase NC NC –2.45 5
AB021980 Fatty acid desaturase 1.22 2.11 –3.4 5
NM_024132 Fatty acid amide hydrolase NC NC –2.11 5
NM_012556 Fatty acid binding protein 1 NC NC –3.92 7
NM_030832 Fatty acid binding protein 7 NC NC –3.79 7
AW534367 Prohepcidin –7.57 –3.42 10.0 2
Abbreviations: NC, no change in expression; NS, gene was not shown in Figure 3 cluster. 
aAccession numbers are from GenBank (http://www.ncbi.nlm.nih.gov).
Table 4. Summary of regulated genes for Aroclor 1254, 3-MC, and CPCA.
Identiﬁed in Previously unknown
Compound Regulated genes Sub. hyb. sequences
Aroclor 1254 4,266 817 252
3-MC 5,005 892 251
CPCA 5,471 953 253
Sub. hyb., subtractive hybridization library.proliferators, aryl hydrocarbon receptor
agonists, and noncoplanar polychlorinated
biphenyls. Similar to our results, the
authors found the arrays they constructed
were able to classify the toxicants into dif-
ferent categories on the basis of mechanism
of toxicity. While our current microarray
has 25,000 sequences represented, almost
certainly this number can be reduced once
a large number of structurally and mecha-
nistically distinct hepatotoxins have been
tested. However, having a large number of
sequences represented has obvious advan-
tages. For instance, on the basis of our
results, it is quite clear that the aromatic
hydrocarbons and CPCA have vastly differ-
ent effects on the liver. CPCA regulated
over 1,000 genes in the liver that were not
regulated by either Aroclor 1254 or 3-MC
(Figure 3). However, the compounds did
regulate approximately 800 genes in com-
mon; the genes regulated in common were
both high- and low-level expression genes.
With a smaller array that might have only a
subset of these genes present, the potential
exists that it would be more difﬁcult to dis-
tinguish between an aromatic hydrocarbon
and an inhibitor of mitochondrial β-oxida-
tion. Clearly, if the concept of guilt by
association is to prove accurate whereby
compounds are considered to have toxic
liabilities if they closely associate with a
known toxin, it is extremely important to
have the correct genes present that distin-
guish the mechanism of toxicity. This also
applies toward understanding the mecha-
nism behind the manifested toxicity. For
instance, quite possibly the genes impor-
tant for understanding the mechanism of
toxicity of CPCA are represented in the
unique set of genes for this compound. A
smaller array, which might not have these
genes present, would prove ineffective in
aiding our understanding of the mecha-
nism of toxicity of this compound.
With the 25K microarray, we observed
regulation of genes that have been previ-
ously shown to be regulated by aromatic
hydrocarbons and CPCA. This indicates
that our strategy for optimizing oligo-
nucleotide probe selection, using hybridi-
zation kinetics, differential regulation, and
hybridization intensity, was a viable
approach and should prove useful in future
oligonucleotide probe design.
In addition, other genes were shown to
be regulated that have not been previously
associated with the hepatotoxins we tested.
For instance, endoplasmic reticulum pro-
tein p29 (Erp29) was upregulated by both
3-MC and Aroclor 1254 treatment. Erp29
is a recently cloned gene shown to be a
member of the endoplasmic reticulum
stress-response machinery (Mkrtchian et al.
1998). Both 3-MC and Aroclor 1254 cause
hypertrophy in the liver as a result of prolif-
eration of the endoplasmic reticulum
(Borlakoglu et al. 1991). Both 3-MC and
Aroclor 1254 also downregulated the liver
tricarboxylate carrier gene. The protein
product of the liver tricarboxylate carrier
gene functions to transport citrate and
malate from the rat liver mitochondria.
Previous research has shown that the func-
tion of the protein is reduced in conjuction
with altered lipid accumulation in the liver,
hepatocyte apoptosis, and hepatic hyperpla-
sia, all of which occurred because of treat-
ment with 3-MC and Aroclor 1254 (Dini
et al. 1999, Waring et al. 2001b).
Although it has been shown that CPCA
inhibits mitochondrial β-oxidation, the
mechanism by which this occurs is not well
understood. Interestingly, peroxisomal pro-
liferators, which also inhibit mitochondrial
β-oxidation, result in an increase in peroxi-
somal β-oxidation and an upregulation of
fatty acid binding protein (Kaikaus et al.
1993). Our results with CPCA show that it
inhibits peroxisomal β-oxidation and
downregulates fatty acid binding protein,
suggesting that CPCA inhibits mitochondr-
ial β-oxidation by a mechanism other than
the peroxisomal proliferators. In addition,
CPCA upregulated prohepcidin, which is a
liver-speciﬁc gene that is overexpressed with
iron overload and may be also upregulated
during oxidative stress (Pigeon et al. 2001).
Overall, we believe our strategy for
designing a rat toxicology microarray has
great advantages. This type of strategy can
be applied toward other systems as well and
should prove beneficial in the design of
new microarrays.
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